Nonacog alfa

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameNonacog alfa
Drug Alias Name凝血素-9α/重组凝血因子IXRecombinant Factor IX (Pfizer/SOBI)Nonacog α/Coagulation Factor IX (Recombinant)诺那凝血素α/重组凝血因子IXNonacog alpha/Coagulation Factor IX (Recombinant) +[10] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant coagulation factor
Mechanisms of ActionCoagulation factor X stimulantsBlood coagulation pathway activation
TargetsCoagulation factor X
Therapy Area/IndicationsHemophilia B
Global Approved IndicationsHemophilia B
Approved Indications in ChinaHemophilia B
Original Approved Country/TerritoryEU
Original Approved Date1997/08/27
Country/TerritoryBulgariaCanadaUnited States +[19] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesPfizer IncPfizer Europe Ma Eeig
Inactive CompaniesWyeth LlcWyeth Farma SaWyeth Pharmaceuticals Inc +[5] 
Active IndicationsHemophilia B
Inactive IndicationsN/A

Other Information

ATC CodeB02BD04
Related LinksDrugBankKEGG